ALPINE IMMUNE SCIENCES, INC. Deferred Tax Assets, Net of Valuation Allowance
ALPINE IMMUNE SCIENCES, INC. had Deferred Tax Assets, Net of Valuation Allowance of $1.96 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2024-03-20
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.96M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.24M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.31M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.24M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2023-12-31 | $1.96M 10-K · filed 2024-03-20 |
| 2022-12-31 | $2.24M 10-K · filed 2024-03-20 |
| 2021-12-31 | $2.31M 10-K · filed 2023-03-23 |
| 2020-12-31 | $2.24M 10-K · filed 2022-03-17 |
| 2019-12-31 | $2.36M 10-K · filed 2021-03-18 |
| 2018-12-31 | $190.00K 10-K · filed 2020-03-30 |
| 2017-12-31 | $115.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $218.00K 10-K · filed 2018-03-28 |
| 2015-12-31 | $3.00K 10-K · filed 2017-02-13 |
| 2014-12-31 | $10.00K 10-K · filed 2016-03-08 |